FDA Investigator Sonya M Edmonds

Sonya M Edmonds has inspections in 7 countries as of 17 Oct 2023. Sonya M Edmonds has collaborated with a combinined 3876 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
57
Last Inspection Date:
17 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, India, Hungary, Korea (Republic of), Spain, Japan
Co-Investigator(s):
Abdollah Koolivand, Adam R Cooke, Alicia M Mozzachio, Alifiya H Ghadiali, Amy Devlin, PhD, Amy H Ruble, Anastasia M Shields, Ann B Borromeo, Ashutosh Rao, PhD, Babatunde D Babalola, Barbara M Frazier, Bernadette T Tallman, Betsy C Galliher, Bo Chi, PhD, Bonita S Chester, Brandon C Heitmeier, Brandy D Brown, Brett D Weed, Brett Weed, Brown, Buford, Burnell M Henry, Carl A Huffman, III, Cassandra L Abellard, CDR Ileana Barreto Pettit, CDR Thomas R Berry, PPh, Charanjeet Jassal, Chestnut, Chris Alexander, Christian D Lynch (CDL), Christopher Downey, PhD, Christopher J Adams, Christopher S Keating, Claudette D Brooks, Clifton L Randell, Constance Y Fears, Contractor Bridgers, Cynthia Jim, CSO, Daniel C Kearns, Daniel Lagasse, Daphne Santiago, PhD, Darryl T Newell, David E Lowe, David Williams, Davinna Ligons, PhD, Deborah A Greco, Demario L Walls, Denise M Digiulio, Desiree D Clark, Devaugh Edwards, Devaughn Edwards, Deyaa Shaheen, Diane E Bruce, Diane P Goyette, Doan T Nguyen, PharmD, Dorothy P Kramer, Dr. Jason R Caballero, Dr. Sriram Subramaniam, PhD, Edward Deberry, Edward Lukeman, Eileen J Bannerman, Ennan Guan, Ephrem Hunde, PhD, Eric S Weilage, Esther C Broner, PhD, Fabian Nchaparro Rodriguez, Frank Wackes, Frederick Razzaghi, Gabriel R Mclemore, Gam S Zamil, Gamal A Norton, Gary E Coleman, Jr, REHS, Gene D Arcy, George J Flynn, Gideon N Esuzor, Gregory Price, Hai Lent Phung, Hai Lien T Phung, Hala L Selby, Ibad U Khan, Inga M Warr, Jacek Cieslak, PhD, Jacqueline Mdiaz Albertini, James A Crim, James P Lewis, Jr, Jamie L Port, Jared P Stevens, Jason F Chancey, Jason K Morgan, Jawaid Hamid, Jee Chung, PhD, Jeff M Uriarte, Jennifer Lalama, Jessica L Pressley, Joanne E King, Joanne T Gabay, John E Aghadia, Johnson, Jose M Cayuela, Joseph F Owens, Julie D Bringger, June P Page, Karen Takahashi, Kassa Ayalew, MD, Kathleen D Culver, Katrina B Mosley Sloan, Kemejumaka N Opara, Khalid M Khan, Kshitij A Patkar, Lareese K Thomas, Larry K Hampton, Latorie S Jones, Laurie B Frazier, Laurie P Norwood, Lauryl A Smith, Leo J Lagrotte, Leopold Kong, PhD, Lesley K Satterwhite, Leslie Arivera Rosado, PhD, Libia M Lugo, Lillie D Witcher, LT Daveta L Bailey, LT Tamara J Henderson, Luis A Carrion, Luis M Burgos Medero, Marcia A Worley, Margaret M Annes, Marie F Morin, Marisa E Stock, Marla A Cassidy, Marvin D Jones, Mary Jeanet Mcgarry, Mary Kaulee, Melanie M Walker, Metitia G Sanders, Metitia M Gramby, Michael F Skelly, PhD, Michelle D Haamid, Michelle Haamid, Narong Chamkasem, PhD, Nicole A Lloyd, Nicole E Knowlton, Nicole M Bell, Noreen Muniz, Nydia E Colon, Patricia F Hughes, PhD, Paul A Bonneau, Paul L Figarole, Jr, Paula A Trost, Penny H Mccarver, Perry H Gambrell, Philip F Istafanos, DMV, MS, Postelle Birch Smith, Postelle D Birch Smith, Prajakta A Varadkar, Pratik S Upadhyay, DDC, R Edwadebey Deberry, Rachael A Moliver, Rachael L Cook, Randy L Clarida, Rashonda N Rucker, Reba A Gates, Rebecca Rodriguez, Regan T Harp, Robert C Coleman, Robert D Tollefsen, Robin N Goins, Rose Xu, Samantha J Bradley, Samuel L Murray, Sarah L Holliday, Saundrea A Munroe, Sayeeda Hdabe, Scott T Ballard, Seneca D Toms, Sharna D Pratt, Shelby N Marler, Simon Williams, PhD, Song Y Lavalais, Srinivas R Chennamaneni, PhD, Srira Subramaniam, PhD, State Agency, Steven D Dittert, Steven Fong, MS, PhD, Steven M Weinman, Susan W Ting, Suzanne N Vallez, Tajah L Blackburn, Tallman, Tamara M Casselman, Tamara M Felton, Tammara A Stephens, Teresa C Thompson, Thomas J Arista, Thuy T Nguyen, LCDR, Tim Lee, Timothy T Kapsala, Tracy R Ball, Trang N Cox, Tsedenia Woldehanna, Veronica Fuentes, MS, Vilmary Negron Rodriguez, Vincent Thomas, Viviana Matta, Wayne S Fortenberry, Wendy G Tan, PhD, Williams, Xiaoxiao Pan, PhD, Xiomara Copeland, Xuhong Li, Yasamin Ameri, Young Kim, Yuan Chia Kuo, Yun Wu, PhD, Zada L Giles, Zhenzhen Liu, PhD, Zhihao Qiu (Peter), PhD

Sonya M Edmonds's Documents

Publish Date Document Type Title
May, 2019 EIR Bestco, LLC - EIR, 2019-05-17
November, 2019 FDA 483 Hospira, Inc. - Form 483, 2019-11-21
May, 2019 FDA 483 Bestco, LLC - Form 483, 2019-05-17
June, 2023 FDA 483 Delta Pharma, Inc. - Form 483, 2023-06-02
August, 2017 EIR Purdue Pharmaceuticals L.P. - EIR, 2017-08-24
March, 2019 FDA 483 Catalent Pharma Solutions, LLC - Form 483, 2019-03-04
February, 2023 FDA 483 Nephron Sterile Compounding Center, LLC - Form 483, 2023-02-10
December, 2016 FDA 483 CMP Pharma, Inc. - Form 483, 2016-12-21
February, 2020 FDA 483 LIVENT USA CORP. - Form 483, 2020-02-07
August, 2022 FDA 483 OUTIN FUTURES CORP. - Form 483, 2022-08-12
September, 2015 FDA 483 Hospira, Inc. - Form 483, 2015-09-24
December, 2015 FDA 483 Eisai Inc - Form 483, 2015-12-10
July, 2016 EIR GlaxoSmithKline - EIR, 2016-07-15
May, 2016 FDA 483 CMP Pharma, Inc. - Form 483, 2016-05-11
August, 2023 FDA 483 PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma - Form 483, 2023-08-02
January, 2019 EIR SpecGx LLC - EIR, 2019-01-25
July, 2018 FDA 483 King Bio Inc. - Form 483, 2018-07-20
April, 2016 FDA 483 GlaxoSmithKline LLC - Form 483, 2016-04-21
February, 2023 FDA 483 Response Nephron Sterile Compounding Center, LLC - Form 483R, 2023-03-06
February, 2016 FDA 483 Advanced Laboratories, Inc. - Form 483, 2016-02-11
July, 2018 FDA 483 Response King Bio Inc. - Form 483R, 2019-02-13
July, 2017 EIR Ambiopharm Inc - EIR, 2017-07-05
August, 2019 EIR Alcami Carolinas Corporation - EIR, 2019-08-09
November, 2019 FDA 483 Response Hospira, Inc. - Form 483R, 2019-12-13
June, 2018 EIR CMP Pharma, Inc. - EIR, 2018-06-28
March, 2022 FDA 483 Family Pharmacy of Statesville - Form 483, 2022-03-11
June, 2018 FDA 483 CMP Pharma, Inc. - Form 483, 2018-06-28
February, 2020 FDA 483 Response LIVENT USA CORP. - Form 483R, 2020-02-21
July, 2017 FDA 483 Ambiopharm Inc - Form 483, 2017-07-05
May, 2016 EIR CMP Pharma, Inc. - EIR, 2016-05-11
May, 2022 FDA 483 Conopco, Inc. d/b/a Unilever - Form 483, 2022-05-27
March, 2019 EIR Catalent Pharma Solutions, LLC - EIR, 2019-03-04
December, 2015 EIR Eisai Inc - EIR, 2015-12-10
September, 2015 EIR Hospira, Inc. - EIR, 2015-09-24
November, 2017 FDA 483 Baxter Healthcare Corporation - Form 483, 2017-11-17
February, 2021 EIR Alcami Carolinas Corporation - EIR, 2021-02-18
December, 2017 FDA 483 Ajinomoto Health & Nutrition North America, Inc. - Form 483, 2017-12-08
December, 2015 FDA 483 Biogen U.S. Corporation - Form 483, 2015-12-10
December, 2017 EIR Ajinomoto Health & Nutrition North America, Inc. - EIR, 2017-12-08
December, 2016 EIR CMP Pharma, Inc. - EIR, 2016-12-21

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more